Title: Jenny Wagner - Innovator in Therapeutic Resistance Diagnosis
Introduction
Jenny Wagner is an accomplished inventor based in Wedemark, Germany. She is currently associated with Adnagen GmbH, where she contributes her expertise in the field of diagnostics. Although she has not yet been granted any patents, her work is focused on significant advancements in medical technology.
Latest Patent Applications
Jenny Wagner's notable patent application is titled "mRNA and/or Protein of ERCC1 Isoform 3 for Use in Diagnosing a Resistance Against a Therapeutic Agent and Method for Diagnosing a Resistance Against a Therapeutic Agent Using Said mRNA and/or Protein." This application outlines a method for diagnosing resistance against therapeutic agents in patients. The method involves measuring the amount of ERCC1 isoform 3 protein and/or mRNA present in a liquid or tissue sample obtained from the patient. The measured amount is then compared to a predetermined value, where an amount above this value indicates resistance against the therapeutic agent.
Conclusion
Jenny Wagner is making strides in the field of diagnostics, particularly in understanding therapeutic resistance. Her innovative approach has the potential to impact patient care significantly.